Tag: iShares U.S. Pharmaceuticals ETF

Trump tariff fallout: Some industries grapple with lingering effects one year later

Trump administration prepares up to 100% pharmaceutical tariffs on some imported drugs

Novo Nordisk says Wegovy pill outperforms Lilly’s oral GLP-1 in cross-trial comparison

Eli Lilly opposes push to pass Trump’s drug pricing deals into law, CEO says

FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market

Stocks soar on hopes of Iran war resolution — plus, Lilly takes a big swing in sleep disorders

Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs

Eli Lilly reaches $2.75 billion deal with Insilico to bring AI-developed drugs to the global market

AstraZeneca stock jumps after surprise trial win for lung disease drug where rivals have failed

Pfizer to seek FDA approval for Lyme disease vaccine candidate despite trial miss